XML 35 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Note P - Share-based Compensation
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]

NOTE P—SHARE-BASED COMPENSATION

  

Equity Plans 

                          

The Company’s board of directors and stockholders approved the following equity plans:

  

 

the 1998 Share Incentive Plan

 
 

the 2000 Share Incentive Plan

  

 

the 2004 Share Incentive Plan

  

 

the 2006 Share Incentive Plan

  

 

the Amended and Restated 2013 Equity Incentive Plan (“2013 Plan”)

  

The Company issued stock options, restricted stock awards (“RSAs”) and restricted stock units (“RSUs”) to employees, consultants and non-employee directors. Stock option awards generally vest over a four year period and have a maximum term of ten years. Stock options under these plans have been granted with an exercise price equal to the fair market value on the date of the grant. Nonqualified and Incentive Stock Options, RSAs and RSUs may be granted from these plans. Prior to the Company’s initial public offering in September 2013, the fair market value of the Company’s stock had been historically determined by the board of directors and from time to time with the assistance of third party valuation specialists.

  

Stock Options 

  

Options have been granted to the Company’s employees under the five incentive plans and generally become exercisable as to 25% of the shares on the first anniversary date following the date of grant and semi-annually thereafter. All options expire ten years after the date of grant.

  

The following is a summary of option activity (in thousands, except per share data):

  

          

Weighted

      

Weighted

     
      

Weighted

  

Average

      

Average

     
      

Average

  

Share Price

  

Weighted

  

Remaining

  

Aggregate

 
  

Number of

  

Exercise

  

on Date of

  

Average

  

Contractual

  

Intrinsic

 
  

shares

  

Price

  

Exercise

  

Fair Value

  

Life

  

Value

 
  

(in thousands, except price data)

 

Outstanding, January 1, 2020

  281  $5.32      $5.32   3.62  $573 

Exercised

  (5)  6.00  $10.77   0.41       24 

Forfeited

                    

Outstanding, December 31, 2020

  276   10.29       5.41   2.67   54 

Exercisable, December 31, 2020

  281   10.21       5.41   2.67   54 

Vested and expected to vest

  276   10.29       5.41   2.67   54 

 

As of December 31, 2020, there was no unrecognized stock option expense.

  

Restricted Stock Unit/Awards

  

The following is a summary of RSU/RSA activity (in thousands, except per share data):

  

      

Weighted

         
      

Average Share

  

Weighted

  

Aggregate

 
  

Number of

  

Price on Date

  

Average Fair

  

Intrinsic

 
  

shares

  

of Release

  

Value

  

Value

 
  

(in thousands, except price data)

 

Outstanding at January 1, 2020

  770      $25.18  $9,143 
Granted  1,201       11.39   13,677 

Released

  (605) $20.83   20.83   6,911 

Cancelled/Forfeited

  (40)      15.27   342 

Outstanding, December 31, 2020

  1,325       14.97   11,279 
Vested and expected to vest  1,325       14.97   11,279 

 

The aggregate intrinsic value of RSUs and RSAs outstanding at December 31, 2020 was $11.3 million. Unrecognized compensation expense related to these RSUs and RSAs at December 31, 2020 was $16.9 million. This expense is expected to be recognized over 2.35 years.

  

Share-Based Compensation 

  

The Company recognizes compensation expense on a straight-line basis over the applicable vesting term of the award and expense is adjusted as forfeitures occur.

  

In 2014, the Company ceased issuing stock options and began issuing RSUs and RSAs as share-based compensation to employees. The Company estimates the fair value of RSUs and RSAs at the fair market value on the grant date.

  

Employee share-based compensation expenses recognized for the years ended December 31, were as follows (in thousands):

  

Share-Based compensation - by expense type:

  

  

2020

  

2019

  

2018

 

Cost of goods sold

 $937  $772  $795 

Research and development

  2,812   2,557   2,419 

Sales and marketing

  1,191   1,070   925 

General and administrative

  8,106   7,405   6,981 

Total share-based compensation expense

 $13,046  $11,804  $11,120 

 

Share-Based compensation - by award type:

  

  

2020

  

2019

  

2018

 

Employee stock options

 $  $  $12 

Restricted stock units

  13,046   11,804   11,108 

Total share-based compensation expense

 $13,046  $11,804  $11,120